Mar 18, 2025 · Dupilumab (Dupixent) is used to treat eczema, asthma, chronic rhinosinusitis with nasal polyps, COPD with an eosinophilic phenotype, eosinophilic esophagitis, or prurigo …

Mar 18, 2025 · Applies to dupilumab: subcutaneous solution. Serious side effects of dupilumab. Along with its needed effects, dupilumab may cause some unwanted effects. Although not all …

Dupilumab se utiliza cuando otros tratamientos tópicos no fueron eficaces o dejaron de funcionar. Dupilumab también se utiliza junto con otros medicamentos para el tratamiento de …

Mar 11, 2025 · Dupixent (dupilumab) has demonstrated significant efficacy in treating eosinophilic esophagitis (EoE) across various patient populations, from children to adults. Multiple clinical …

Mar 25, 2024 · Detailed Dupilumab dosage information for adults and children. Includes dosages for Asthma, Sinusitis, Atopic Dermatitis and more; plus renal, liver and dialysis adjustments.

Dec 10, 2024 · Dupilumab did not alter immune response to tetanus antigen; immune responses to diphtheria and pertussis antigens not assessed. Vaccines, live. Not known if administration …

Oct 10, 2024 · Dupixent (generic name: dupilumab) can start to work in 2 to 4 weeks to relieve symptoms associated with inflammatory conditions like eczema, asthma, and sinus swelling …

Dupilumab Interactions There are 91 drugs known to interact with dupilumab , along with 3 disease interactions. Of the total drug interactions, 43 are major, 39 are moderate, and 9 are …

Dupilumab (Ingredient) Drugbank ID: DB12159. The information below refers to products available in the United States that contain dupilumab. Products containing dupilumab …

Dupixent (dupilumab) is an interleukin-4 receptor alpha antagonist used for the treatment of atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, …